BDBM18964 4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol::L 3372::NSC85438::US9725430, Compound 1b::US9962362, Compound 1b
SMILES: CCCCc1oc2ccccc2c1C(=O)c1ccc(O)cc1
InChI Key: InChIKey=ZHGKQUXXASLVQQ-UHFFFAOYSA-N
Data: 8 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thyroid Hormone Receptor (TR-alpha) (Gallus gallus (chicken)) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >2.00E+6 | n/a | n/a | n/a | n/a | 7.6 | 22 |
University of Amsterdam | Assay Description IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRalpha. | Endocrinology 137: 2807-14 (1996) Article DOI: 10.1210/endo.137.7.8770901 BindingDB Entry DOI: 10.7270/Q2ZK5DX4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
thyroid beta (RAT) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >2.00E+6 | n/a | n/a | n/a | n/a | 7.6 | 22 |
University of Amsterdam | Assay Description IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRbeta. | Endocrinology 137: 2807-14 (1996) Article DOI: 10.1210/endo.137.7.8770901 BindingDB Entry DOI: 10.7270/Q2ZK5DX4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Eyes absent homolog 3 (EYA3) (ED) (Homo sapiens (Human)) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 1.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CHILDREN HOSPITAL MEDICAL CENTER US Patent | Assay Description An inhibitory assay was conducted using the previously described p-nitrophenylphosphate assay (Rayapureddi, J. P. et al. Nature 426, 295-298 (2003)).... | US Patent US9725430 (2017) BindingDB Entry DOI: 10.7270/Q23F4RSZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-tyrosine phosphatase 1B (Homo sapiens (Human)) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 7.14E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GNF | Assay Description The compounds were then tested using full-length human recombinant, purified EYA3 and pNPP as a substrate. Compounds were dissolved in DMSO and dilut... | Bioorg Med Chem Lett 16: 5488-92 (2006) BindingDB Entry DOI: 10.7270/Q2ZK5JZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-tyrosine phosphatase 1B (PTP1B) (Homo sapiens (Human)) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 7.14E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CHILDREN HOSPITAL MEDICAL CENTER US Patent | Assay Description An inhibitory assay was conducted using the previously described p-nitrophenylphosphate assay (Rayapureddi, J. P. et al. Nature 426, 295-298 (2003)).... | US Patent US9725430 (2017) BindingDB Entry DOI: 10.7270/Q23F4RSZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EYA3(ED) (Mus musculus (Mouse)) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 1.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GNF | Assay Description The compounds were then tested using full-length human recombinant, purified EYA3 and pNPP as a substrate. Compounds were dissolved in DMSO and dilut... | Bioorg Med Chem Lett 16: 5488-92 (2006) BindingDB Entry DOI: 10.7270/Q2ZK5JZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Eyes absent homolog 3 (EYA3) (Homo sapiens (Human)) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | UniProtKB/SwissProt GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 1.52E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GNF | Assay Description The compounds were then tested using full-length human recombinant, purified EYA3 and pNPP as a substrate. Compounds were dissolved in DMSO and dilut... | Bioorg Med Chem Lett 16: 5488-92 (2006) BindingDB Entry DOI: 10.7270/Q2ZK5JZ7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Eyes absent homolog 3 (EYA3) (Homo sapiens (Human)) | BDBM18964 (4-[(2-butyl-1-benzofuran-3-yl)carbonyl]phenol | L ...) | UniProtKB/SwissProt GoogleScholar AffyNet | Purchase KEGG PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 1.52E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
CHILDREN HOSPITAL MEDICAL CENTER US Patent | Assay Description An inhibitory assay was conducted using the previously described p-nitrophenylphosphate assay (Rayapureddi, J. P. et al. Nature 426, 295-298 (2003)).... | US Patent US9725430 (2017) BindingDB Entry DOI: 10.7270/Q23F4RSZ | |||||||||||
More data for this Ligand-Target Pair |